Q: Can you please explain what this means & why it is impacting the price? Thanks!
Vaxart (NASDAQ:VXRT) is down 6% premarket on increased volume. Shares have sold off over 20% since last week after it disclosed a $250M at-the-market stock sales deal with Jefferies.
Vaxart (NASDAQ:VXRT) is down 6% premarket on increased volume. Shares have sold off over 20% since last week after it disclosed a $250M at-the-market stock sales deal with Jefferies.